Hypophosphatemia News and Research

RSS
Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Updated data on XL184 study in patients with glioblastoma multiforme presented

Updated data on XL184 study in patients with glioblastoma multiforme presented

FDA grants marketing approval for Elitek

FDA grants marketing approval for Elitek

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

Genzyme announces results of clinical trials of Renvela and Renagel

Genzyme announces results of clinical trials of Renvela and Renagel

Cancer treatment interferes with bone development

Cancer treatment interferes with bone development